GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma Trading AD (XBUL:SFT) » Definitions » Capex-to-Operating-Income

Sopharma Trading AD (XBUL:SFT) Capex-to-Operating-Income : 0.41 (As of Sep. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Sopharma Trading AD Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Sopharma Trading AD's Capital Expenditure for the three months ended in Sep. 2023 was лв-3.75 Mil. Its Operating Income for the three months ended in Sep. 2023 was лв9.20 Mil.

Hence, Sopharma Trading AD's Capex-to-Operating-Income for the three months ended in Sep. 2023 was 0.41.


Sopharma Trading AD Capex-to-Operating-Income Historical Data

The historical data trend for Sopharma Trading AD's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma Trading AD Capex-to-Operating-Income Chart

Sopharma Trading AD Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Capex-to-Operating-Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.99 1.78 0.59 0.68 0.23

Sopharma Trading AD Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.23 0.28 0.24 0.28 0.41

Competitive Comparison of Sopharma Trading AD's Capex-to-Operating-Income

For the Medical Distribution subindustry, Sopharma Trading AD's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sopharma Trading AD's Capex-to-Operating-Income Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sopharma Trading AD's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Sopharma Trading AD's Capex-to-Operating-Income falls into.



Sopharma Trading AD Capex-to-Operating-Income Calculation

Sopharma Trading AD's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2022 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-9.224) / 40.363
=0.23

Sopharma Trading AD's Capex-to-Operating-Income for the quarter that ended in Sep. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-3.752) / 9.197
=0.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sopharma Trading AD  (XBUL:SFT) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Sopharma Trading AD Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Sopharma Trading AD's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Sopharma Trading AD (XBUL:SFT) Business Description

Traded in Other Exchanges
N/A
Address
Sunrise Street, Lachezar Stanchev, 5 Sopharma, Business Towers, Building A Floor 12, Sofia, BGR, 1756
Sopharma Trading AD is a Bulgaria based company operating in the pharmaceutical sector. The company is engaged in the distribution of pharmaceutical items, including a portfolio of international brands, medicinal products, medical supplies, sanitary and hygienic materials, vitamins, nutritional supplements, cosmetics, medical equipment, and equipment. It also provides turnkey solutions for the construction of medical and hospital establishments. In addition, the group also caters logistics solutions for import, storage, and distribution of goods to end customers.

Sopharma Trading AD (XBUL:SFT) Headlines

No Headlines